 Similarly, the treatment of IC may provide no beneﬁt
to patients with signiﬁcant ischemic or structural heart disease,
chronic obstructive pulmonary disease, morbid obesity, stroke,
etc. In addition, such patients present a greater risk of complications or death, potentially outweighing the beneﬁt of treatment, especially when surgery is required.
Numerous studies have demonstrated the efﬁcacy of
both endovascular and surgical therapy for the relief of
symptoms of cl